TipRanks
Advertisement
Advertisement
Lexaria Extends Cash Runway Through 2027 After $7.9 Million Capital Boost
PremiumCompany AnnouncementsLexaria Extends Cash Runway Through 2027 After $7.9 Million Capital Boost
1M ago
Lexaria Bioscience updates financial position
Premium
The Fly
Lexaria Bioscience updates financial position
1M ago
Lexaria Raises $5.9 Million Via Warrant Exercise and Issues New Warrants
Premium
Company Announcements
Lexaria Raises $5.9 Million Via Warrant Exercise and Issues New Warrants
1M ago
Lexaria Bioscience Regains Nasdaq Compliance, Stabilizing Listing
PremiumCompany AnnouncementsLexaria Bioscience Regains Nasdaq Compliance, Stabilizing Listing
2M ago
Lexaria Bioscience enters MTA with PegBio
Premium
The Fly
Lexaria Bioscience enters MTA with PegBio
2M ago
Lexaria Signs PegBio Deal to Test DehydraTECH With GLP-1 Diabetes Drug
Premium
Company Announcements
Lexaria Signs PegBio Deal to Test DehydraTECH With GLP-1 Diabetes Drug
2M ago
Kneat Shareholders Strongly Back Thoma Bravo Acquisition Deal
PremiumCompany AnnouncementsKneat Shareholders Strongly Back Thoma Bravo Acquisition Deal
3M ago
Lexaria Bioscience announces effective date for reverse stock split
Premium
The Fly
Lexaria Bioscience announces effective date for reverse stock split
3M ago
Lexaria reports ‘positive’ meetings with potential partners at BIO convention
Premium
The Fly
Lexaria reports ‘positive’ meetings with potential partners at BIO convention
4M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―